Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Search Reports


See which reports have been searched on the most.


In the Spotlight

Executive Briefing Thumb

New Country Archetypes Model + Executive Briefing

Country Archetypes: A guided tour of market access around the world

Download Now!

Recent Reports [ view all ]

  • EU5 Market Access Opportunities and Challenges for Current and Emerging RA Agents Amid the Launches of Oral Jak Inhibitors and Biosimilars.

    Rheumatoid arthritis (RA) is a complex autoimmune condition characterized by chronic and progressive joint inflammation... Read More

  • What Market Access Levers and Barriers Will Emerging Biologics for SLE Face in Europe? A Study of EU5 Prescribers and Payers

    In 2011, GlaxoSmithKline’s Benlysta became the first biological treatment ever approved for systemic lupus... Read More

  • Malignant Melanoma - 2014

    The poor prognosis of advanced malignant melanoma (melanoma) patients means that there is a significant need for... Read More

Decision Resources Group brands include: